Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

From the Authors

J. Hunt
European Respiratory Journal 2004 23: 962; DOI: 10.1183/09031936.04.00027504
J. Hunt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

From the authors:

In R.M. Effros' frequent letters in response to data regarding exhaled breath condensate (EBC) pH, there is one constant: he states that his speculations must be correct, despite the accumulation of substantial data to the contrary. To his credit, R.M. Effros now accepts that indeed there are acids involved in the acidification of exhaled breath condensate. Additionally edifying is that, in this current letter, he has not repeated his previous strongly stated, yet incorrect, notions that: pH cannot be measured in EBC; that glass electrodes will provide irreproducible readings; that asthmatic hyperventilation causes EBC acidification; or that facilitated diffusion would cause increased ammonia to be exhaled when the airways are acidic 1. Much data have emerged that have thoroughly negated these notions.

This time R.M. Effros has manufactured a false paradox compelling him to speculate an unnecessary solution. He makes the false assumption that removal of oral ammonia should be acidifying to a relevant degree. Indeed, R.M. Effros' “paradox” disappears when we discard his underlying false assumption. Because EBC pH and ammonia experiments indeed solidly dispel his assumption, we are easily left with no paradox, and an internally consistent set of findings regarding EBC pH.

Although R.M. Effros references his suggested mechanism for artifactual EBC pH decline in asthmatics, we respectfully remind him that the data in our paper specifically and directly disprove his suggestion. Scientists uniformly agree that it is more reasonable to discard hypotheses proven wrong, than to discard data inconsistent with hypotheses.

We have to agree with R.M. Effros that oral ammonia, as a base, should indeed have some alkalinising effect. However, the data show clearly that this effect in EBC is too tiny to be noted without a huge enrollment of subjects, and such a quest is pointless. Neither oral ammonia, nor the lack of it, is responsible for the profound EBC acidification seen in various diseases. Indeed, that EBC acidification is characteristic of intubated patients with lung disease, but not of intubated patients without lung disease 2–4, helps further to dispel R.M. Effros' argument that the mouth is the controller of EBC pH. As part of the airway, the mouth assuredly contributes to EBC. But the mouth is a small part of the airway, and its contribution to EBC may be likewise.

Gastro-oesophageal reflux certainly affects tracheal pH 5, with tracheal pH probe readings falling to 4.0, and therefore we believe aspirated acid to be one mechanism that acidifies EBC. We are convinced that reflux contributes to lung disease, but if reflux is the sole reason why EBC pH falls, then reflux must be a factor in most every lung disease patient, even while intubated, which is more than even the most vocal advocates suggest.

Over the years, we have appreciated R.M. Effros' strongly and repeatedly asserted, albeit incorrect, speculations. Without these thoughtful speculations, we might not have so aggressively and rigorously tested every facet of the exhaled breath condensate pH assay. In the end, exhaled breath condensate pH has proven to be thoroughly robust and entirely useful. Patients with respiratory diseases, including asthma, chronic obstructive pulmonary disease, bronchiectasis 6, cystic fibrosis 7, acute lung injury and acute respiratory distress syndrome 2 exhale more acid. This is particularly true of patients who are undergoing disease exacerbations. To us, this is very interesting indeed both as a marker of disease activity, and as a clue to underlying pathologic mechanisms.

    • © ERS Journals Ltd

    References

    1. ↵
      Effros RM, Bosbous M, Foss B, Shaker R, Biller J. Exhaled breath condensates: a potential novel technique for detecting aspiration. Am J Med 2003;115: Suppl. 3A, 137S–143S.
    2. ↵
      Gessner C, Hammerschmidt S, Kuhn H, et al. Exhaled breath condensate acidification in acute lung injury. Respir Med 2003;97:1188–1194.
      OpenUrlCrossRefPubMedWeb of Science
    3. Moloney ED, Mumby SE, Gajdocsi R, et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am J Respir Crit Care Med 2004;169:64–69.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      Vaughan J, Ngamtrakulpanit L, Pajewski TN, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003;22:889–894.
      OpenUrlAbstract/FREE Full Text
    5. ↵
      Jack CI, Calverley PM, Donnelly RJ, et al. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995;50:201–204.
      OpenUrlAbstract/FREE Full Text
    6. ↵
      Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002;165:1364–1370.
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      Tate S, MacGregor G, Davis M, Innes JA, Greening AP. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002;57:926–929.
      OpenUrlAbstract/FREE Full Text
    PreviousNext
    Back to top
    View this article with LENS
    Vol 23 Issue 6 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    From the Authors
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    From the Authors
    J. Hunt
    European Respiratory Journal Jun 2004, 23 (6) 962; DOI: 10.1183/09031936.04.00027504

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    From the Authors
    J. Hunt
    European Respiratory Journal Jun 2004, 23 (6) 962; DOI: 10.1183/09031936.04.00027504
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Extracorporeal life support as a bridge to lung transplantation strategy in anti-MDA5+ rapidly progressive interstitial lung disease is life-saving but with persistent difficulties at the bedside
    • Liver cancer in severe alpha-1 antitrypsin deficiency: Who is at risk?
    • Cancer risk in severe alpha-1-antitrypsin deficiency - the importance of the early identification
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2022 by the European Respiratory Society